Clinical Study

Comparative Study of the Effects of 1% Atropine on the Anterior Segment

Table 1

The ocular biometry measurements obtained by using UBM with and without cycloplegia.

ParameterMean ± SD value
Before cycloplegiaAfter cycloplegiaMean difference ± SD

TIA (°)38.3 ± 7.5951.44 ± 9.33−13.15 ± 8.53<0.05
AOD500 (mm)0.63 ± 0.190.9 ± 0.25−0.28 ± 0.16<0.05
ACD (mm)3.16 ± 0.233.31 ± 0.21−0.16 ± 0.14<0.05
LV (mm)−0.1 ± 0.17−0.34 ± 0.170.24 ± 0.16<0.05
ACW (mm)12.17 ± 0.6812.03 ± 0.640.14 ± 0.64=0.1
IT750 (mm)0.44 ± 0.10.55 ± 0.1−0.11 ± 0.11<0.05
IT1500 (mm)0.48 ± 0.070.58 ± 0.08−0.1 ± 0.09<0.05
IA (mm2)1.87 ± 0.271.36 ± 0.210.52 ± 0.29<0.05
CBT0 (mm)1.22 ± 0.111.21 ± 0.160.01 ± 0.16=0.52
CMTmax (mm)0.68 ± 0.080.58 ± 0.080.1 ± 0.08<0.05
TCA (°)70.54 ± 13.0286.47 ± 14.39−15.93 ± 16.79<0.05
TCPD (mm)1.06 ± 0.151.18 ± 0.17−0.12 ± 0.19<0.05
ICPD (mm)0.2 ± 0.130.17 ± 0.110.03 ± 0.15=0.14
SIA (°)45.58 ± 6.9661.99 ± 10.62−16.41 ± 9.51<0.05
SCPA (°)52.22 ± 7.8158.93 ± 7.18−6.71 ± 8.93<0.05